Abiopharma

New Form 8-K - Unicycive Therapeutics, Inc. Filed: 2025-06-30 AccNo: 0001213900-25-059303 Size: 231 KB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits